Baylor Health Care System
 
2 4 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Hyperkalemic periodic paralysis

Alternative Names

Paramyotonia congenita; Periodic paralysis - hyperkalemic

Treatment

The goals of treatment are relief of acute symptoms and prevention of further attacks.

Attacks are seldom severe enough to require emergency treatment. However, weakness can become worse with repeated attacks, so treatment to prevent the attacks should occur as soon as possible.

Glucose or other carbohydrates (sugars) given during an attack may reduce the severity. Intravenous calcium or diuretics such as furosemide may be needed to stop sudden attacks. Intravenous glucose and insulin cause potassium to move into the cell and may reduce weakness without a loss of total body potassium.

A high-carbohydrate diet may be recommended.

Acetazolamide, a medication that prevents attacks of familial periodic paralysis, is also effective in preventing attacks of hyperkalemic periodic paralysis. Thiazide diuretics such as chlorothiazide are also effective and have fewer side effects than acetazolamide.

Outlook (Prognosis)

Sometimes attacks disappear later in life on their own. However, chronic attacks generally result in progressive muscle weakness that is present even between attacks.

Hyperkalemic periodic paralysis responds well to treatment. Treatment may prevent, and may even reverse, progressive muscle weakness.

Possible Complications

  • Kidney stones (a side effect of acetazolamide)
  • Heart arrhythmias during attacks (rare, not fatal)
  • Difficulty breathing, speaking, or swallowing during attacks (rare)
  • Progressive muscle weakness

When to Contact a Medical Professional

Call your health care provider if intermittent muscle weakness occurs, particularly if there is a family history of periodic paralysis.

Go to the emergency room or call the local emergency number (such as 911) if fainting, difficulty breathing, difficulty speaking or difficulty swallowing occur. These emergency symptoms are rare.

Review Date: 7/25/2006
Reviewed By: David M. Charytan, M.D., M.Sc., Department of Medicine, Division of Nephrology, Brigham and Women's Hospital, Boston, MA. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission. URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2005 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.